Serum Biomarkers in Parkinson's Disease at Different Stages
Recruiting · NCT05769699 · Interventional (participants receive a specific treatment) · Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
View the official record on ClinicalTrials.gov →Interventions studied
blood sample
What this trial is about
* Determine clinical characteristics of parkinsonian patients in various stages of disease; * Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease. * Measure vesicular neurodegeneration, synaptic and inflammation biomarkers
Who can take part
Age range
18 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria;
- Age: 18-80 years;
- Signature of informed consent to participate in this study
Exclusion criteria
- Women pregnant
- Inflammatory or autoimmune diseases
Where it is running
1 location listed.
- Flavia Torlizzi - Roma, Italy